Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastoma

Highlights • Second primary tumors can be hard to distinguish from retinoblastoma metastases • Molecular analyses for RB1 mutations and somatic copy number changes aids diagnosis • Inverse PCR defines deletion breakpoints, enabling personalized mutation assays

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer genetics 2016-07, Vol.209 (7-8), p.359-363
Hauptverfasser: Racher, Hilary, Soliman, Sameh, Argiropoulos, Bob, Chan, Helen S.L, Gallie, Brenda L, Perrier, Renée, Matevski, Donco, Rushlow, Diane, Piovesan, Beata, Shaikh, Furqan, MacDonald, Heather, Corson, Timothy W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • Second primary tumors can be hard to distinguish from retinoblastoma metastases • Molecular analyses for RB1 mutations and somatic copy number changes aids diagnosis • Inverse PCR defines deletion breakpoints, enabling personalized mutation assays
ISSN:2210-7762
2210-7770
DOI:10.1016/j.cancergen.2016.06.001